Platelet Rich Plasma Market to Grow at 8.3% CAGR till 2022, Increased Bariatric and Cosmetic Surgeries Drive Market

Platelet rich plasma (PRP) is made from the patient’s own blood platelets and has a concentration of platelets above the baseline. It is used for treatment of ligaments, joints, bones, and soft tissues. PRP has a concentration of platelets up to eight times more than normal blood and is thus known as enriched plasma, or platelet enriched gel. Platelet rich plasma (PRP) helps in the treatment of cardiothoracic, orthopedic, and neurological diseases, and several other ailments. Platelet rich plasma (PRP) is also used extensively in cosmetic surgeries, minor injuries, osteoarthritis, and fractures. The Europe market for platelet rich plasma (PRP) is expanding at a CAGR of 8.3% and is projected to reach US$87.2 million in 2022. Demand for platelet rich plasma (PRP) is expected to increase due to awareness of the multiple advantage of PRP therapy. Another key factor boosting the platelet rich plasma (PRP) market is the growing geriatric population in need of surgeries and treatments for various age-related ailments.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4761

Upsurge in obesity among the male as well as female populations in Western Europe has resulted in rising bariatric surgeries and this factor is among the major market drivers for PRP in this region. Other factors responsible for market growth of platelet rich plasma (PRP) are the increasing number of cosmetic surgeries and technological advancements in devices and regulatory approvals.

Pure PRP Leads Demand from Europe PRP market due to High Platelet Content

The Europe platelet rich plasma (PRP) market is segmented based on application, types, and origins. In the type-based segmentation, pure PRP accounted for 70.8% of the Europe market share and was the largest market segment in 2013. This fact was attributed to the higher platelet content of pure PRP than other product segments. The L-PRP segment is estimated to have high growth prospects over the next few years, due to benefits such as ease of preparation, reduced healing time, high leukocyte content, and economical factors. The autologous product segment in the platelet rich plasma (PRP) market also had a large market share in 2013 and is estimated to increase in demand over the next decade. The rise in demand for this segment can be attributed to high need for allogeneic platelet rich plasma products for treatment of patients with blood disorders.

Demand for Orthopedic Application Increases Due to Wide Usage

In the application segment, orthopedic application had the largest share due to multiple orthopedic treatments. In 2013, the orthopedic application segment held 38% of the market for PRP in Europe. The orthopedic segment widely uses PRP for sports injuries and treatment related to geriatric ailments and surgeries. The cosmetic application segment of the platelet rich plasma (PRP) market has great potential for market expansion during the years leading to 2022.

Geographical segments of the Europe platelet rich plasma (PRP) market are Germany, the U.K., France, Italy, Spain, and the rest of Europe. The U.K. had the largest market share in 2013 owing to escalation in reconstructive procedures, bariatric surgeries, and orthopedic surgeries. Europe comprises numerous large and small multinational market players for platelet rich plasma (PRP). In 2013, EmCyte Corporation, Arthrex, Inc., and Biomet, Inc. dominated the market. 

Browse Full Global Lubrication Systems Market Report With Complete TOC @ http://www.transparencymarketresearch.com/europe-platelet-rich-plasma-market.html

About Us: 
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/